HIV 101: Initiation of Antiretroviral Therapy and Primary Care for People With HIV


Michael S. Saag, MD
University of Alabama at Birmingham
Melanie Thompson, MD
Melanie A. Thompson, MD
Thacker & Thompson, MD


September 28, 2022 - 9:00 AM


September 28, 2022 - 10:30 AM

Add to iCal Calendar


Assessment of Needs

This webinar is designed for HIV or infectious disease residents, fellows, and advanced practitioners who are new to the field of HIV research and management. In the webinar, experts in the field will describe the core principles of HIV management, including pathogenesis of HIV infection, mechanism of action of antiretroviral drugs, initiating antiretroviral therapy, and primary care for people with HIV. This webinar will also be useful to experienced clinicians who seek a review of these core principles.

Learning Objectives

At the end of this webinar, participants will be able to:

  • Describe basic mechanisms of antiretroviral therapy
  • Describe antiretroviral regimens based on patient parameters
  • Conduct an initial assessment for a person with HIV
  • Provide appropriate vaccinations for people with HIV, focusing on pneumococcus, hepatitis B, SARS-CoV-2, and monkeypox
  • Assess cardiovascular risk in people with HIV
  • Screen for and manage polypharmacy and frailty


View the on-demand recording of our webinar on the Fundamentals of HIV Infections and Application of Antiretroviral Therapy, presented on September 29, 2021, by Michael S. Saag, MD of the University of Alabama at Birmingham. Complete the preactivity assessment here.


Who Should Attend

This webinar is designed for clinical decision makers who are in training, new to, or are interested in a review of HIV patient care, including physicians, physician assistants, nursing professionals, pharmacists, and other health care professionals.

Though attendance for the 2022 Ryan White HIV/AIDS CLINICAL CONFERENCE is limited to HIV physicians, nurse practitioners, physician assistants, and primary clinical decision makers in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs, registration for this webinar is open to all.

Individual registration is required in order to receive CME credit or a certificate of participation.

Registration closes on Wednesday, September 28, 2022, 9:30 AM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, faculty, Scientific Leadership Board, Governance Board, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.  

The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” 

IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenter and planners/reviewers is below and in the slides prior to the presentation of educational content.


Dr Saag has received research grants and support awarded to his institution from Gilead Sciences, Inc and ViiV Healthcare. (Updated 07/19/22)

Dr Thompson’s institution has received research grants from Gilead Sciences, Inc, Merck Sharp Dohme, and ViiV Healthcare. She has served on advisory and data safety monitoring boards for Excision Biotherapeutics. (Updated 07/19/22)


Planner/Reviewer 1 has no relevant financial relationships with ineligible companies to disclose. (Updated 07/19/22)
Planner/Reviewer 2 has no relevant financial relationships with ineligible companies to disclose. (Updated 07/19/22)

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this blended activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. IAS-USA, the CME activity provider, will submit your participant information (eg, name, date of birth, activity credits earned, ABIM MOC number) to ABIM through the PARS system for the purpose of reporting ABIM MOC credits.

Nursing Credits

Educational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 2 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California (Provider # 14692), the state of Florida and the District of Columbia.

Pharmacy Credits

Accreditation Council for Pharmacy Education logo Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.   Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 2 contact hours (0.2 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN  # 0761-9999-22-404-L02-P

Grant Support

This preconference webinar is funded by Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U1OHA28686 (AIDS Education and Training Center National Coordinating Resource Center) awarded François-Xavier Bagnoud Center from the Rutgers University School of Nursing with a sub award to International Antiviral Society–USA (IAS–USA) to sponsor this CME activity.

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at or 415-544-9400.